2031: Q&A with Oncimmune CEO, Martin Gouldstone
Jan 31 2025
Length: 9 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wish list failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

2031: Q&A with Oncimmune CEO, Martin Gouldstone

Listen for free

View show details

Summary
Watch on YouTube

After this morning's trading update, CEO Martin Gouldstone of Oncimmune - a leading life sciences firm providing autoantibody profiling services to the Biopharma industry – takes me through the company's current demand picture, pipeline and August FY25 guidance.

Show more Show less

Show more Show less

What listeners say about 2031: Q&A with Oncimmune CEO, Martin Gouldstone

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews

No reviews are available

Report a review on Amazon